These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20089376)

  • 1. Reproductive hormone exposure timing and ischemic heart disease: Complicated answers to a simple question.
    Bairey Merz CN; Shufelt C; Johnson BD; Azziz R; Braunstein GD
    Maturitas; 2010 Apr; 65(4):297-8. PubMed ID: 20089376
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: "Reproductive hormone exposure timing and ischemic heart disease: complicated answers to a simple question" by Merz et al. [Maturitas 65 (2010) 297-298].
    Dören M; Greiser EM
    Maturitas; 2010 Jul; 66(3):329; author reply 329-30. PubMed ID: 20418031
    [No Abstract]   [Full Text] [Related]  

  • 3. Reproductive and hormonal factors and risk of cognitive impairment among Singapore Chinese women.
    Song X; Wu J; Zhou Y; Feng L; Yuan JM; Pan A; Koh WP
    Am J Obstet Gynecol; 2020 Sep; 223(3):410.e1-410.e23. PubMed ID: 32112728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atherosclerosis and menopause].
    Alegría E; Velasco S; Bolao IG; Iglesias I
    Rev Med Univ Navarra; 1994; 39(2):57-60. PubMed ID: 7724962
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of hormone-replacement therapy and steroid contraceptives in menopause as an oncological and epidemiological problem: is it a risk and/or benefit?].
    Bershteĭn LM
    Vopr Onkol; 2005; 51(6):636-46. PubMed ID: 17037027
    [No Abstract]   [Full Text] [Related]  

  • 6. [Is menopause a risk factor for ischemic heart disease in women?].
    Leuzzi C; Marzullo R; Modena MG
    G Ital Cardiol (Rome); 2012 Jun; 13(6):401-6. PubMed ID: 22622118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A low dosage pile, until menopause, will facilitate medical practice.. Interview by Robert Henry].
    Rioux JE
    Union Med Can; 1993; 122(4):242-6. PubMed ID: 8367910
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral contraceptives, replacement oestrogens and the risk of rheumatoid arthritis.
    Hernandez-Avila M; Liang MH; Willett WC; Stampfer MJ; Colditz GA; Rosner B; Chang RW; Hennekens CH; Speizer FE
    Br J Rheumatol; 1989; 28 Suppl 1():31; discussion 42-5. PubMed ID: 2819344
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hormone replacement therapy (HRT) for hyperlipidemia after menopause].
    Sakuma I; Kitabatake A
    Nihon Rinsho; 2002 May; 60(5):1025-31. PubMed ID: 12029981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Grant EC
    J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
    [No Abstract]   [Full Text] [Related]  

  • 11. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study.
    Jacobsen BK; Knutsen SF; Fraser GE
    J Clin Epidemiol; 1999 Apr; 52(4):303-7. PubMed ID: 10235170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contemporary views on estrogen replacement therapy. II. Hormonal therapy in women with imminent ischemic heart disease].
    Krasomski G
    Ginekol Pol; 1995 Feb; 66(2):93-6. PubMed ID: 8575683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS.
    Lee E; Horn-Ross PL; Rull RP; Neuhausen SL; Anton-Culver H; Ursin G; Henderson KD; Bernstein L
    Am J Epidemiol; 2013 Nov; 178(9):1403-13. PubMed ID: 24008905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case-control study of reproductive factors, female hormone use, and risk of pancreatic cancer.
    Zhang Y; Coogan PF; Palmer JR; Strom BL; Rosenberg L
    Cancer Causes Control; 2010 Mar; 21(3):473-8. PubMed ID: 19941157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrogen therapy for myocardial ischaemia in women.
    Williams JK
    Lancet; 1993 Jul; 342(8864):128. PubMed ID: 8101247
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormone replacement therapy and ischaemic heart disease: continuing questions but still no answers.
    Lloyd G
    Int J Clin Pract; 2000 Sep; 54(7):416-7. PubMed ID: 11070562
    [No Abstract]   [Full Text] [Related]  

  • 17. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression.
    Clarkson TB
    Menopause; 2018 Nov; 25(11):1262-1274. PubMed ID: 30358722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Menopause. Hormone substitution therapy and prevention of cardiovascular risk].
    Grio R; Cellura A; Porpiglia M; Geranio R; Piacentino R
    Minerva Ginecol; 1998; 50(7-8):329-31. PubMed ID: 9808958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment.
    Milman N; Kirchhoff M; Jørgensen T
    Ann Hematol; 1992 Aug; 65(2):96-102. PubMed ID: 1511065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.